ConductScience.org, home

Paper32077604

Optimal management of chronic hepatitis B patients receiving nucleos(t)ide analogues.

Buti M and 3 others. Liver Int, 2020. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Optimal management of chronic hepatitis B patients receiving nucleos(t)ide analogues. Papers, record 32077604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32077604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Optimal management of chronic hepatitis B patients receiving nucleos(t)ide analogues.
PubMed
Journal
Liver Int
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.84
iCite
Revised in PubMed
2021-06-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Buti MMaria
2Roade LLuisahttps://orcid.org/0000-0002-8160-9613
3Riveiro-Barciela MMar
4Esteban RRafael

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Hepatitis B, ChronicMajor topic
Liver NeoplasmsMajor topic
Antiviral Agents
Humans
Treatment Outcome

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42325368HBsAg loss in HIV/HBV coinfected patients: Hepatitis B cure insights and implications.Infect Dis Immun2025https://conductscience.org/library/papers/42325368PubMed
41810101Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China.J Clin Transl Hepatol2026https://conductscience.org/library/papers/41810101PubMed
40890755Global trends and insights in interferon therapy for chronic hepatitis B: a bibliometric analysis.Virol J2025https://conductscience.org/library/papers/40890755PubMed
40667578Duration of Nucleos(t)ide Analogue Treatments in Patients With Chronic Hepatitis B Virus Infection in the United States.J Viral Hepat2025https://conductscience.org/library/papers/40667578PubMed
40653613Clinical Features of HBV-Related HCC in Long-Term NAs-Treated Versus Untreated Patients.J Cell Mol Med2025https://conductscience.org/library/papers/40653613PubMed
39101697Etiologies of Persistent Aminotransferase Elevations in Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogs.Turk J Gastroenterol2024https://conductscience.org/library/papers/39101697PubMed
38689751Prospective study of hepatitis B and D epidemiology and risk factors in Romania: A 10-year update.World J Hepatol2024https://conductscience.org/library/papers/38689751PubMed
35836769Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China.J Clin Transl Hepatol2022https://conductscience.org/library/papers/35836769PubMed
34630679Efficacy and safety of tenofovir alafenamide fumarate in nucleoside analogue treatment-naïve patients with chronic hepatitis B.Exp Ther Med2021https://conductscience.org/library/papers/34630679PubMed
33905426Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.PLoS One2021https://conductscience.org/library/papers/33905426PubMed
33614029Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B.Ther Adv Infect Dis2021https://conductscience.org/library/papers/33614029PubMed
32596332The Risk of Acute Kidney Injury in Hepatitis B Virus-Related Acute on Chronic Liver Failure with Tenofovir Treatment.Biomed Res Int2020https://conductscience.org/library/papers/32596332PubMed
32384507Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis.Medicine (Baltimore)2020https://conductscience.org/library/papers/32384507PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32077604

GET https://conductscience.org/api/papers/v1/32077604/authors